Atorvastatin相关论文
目的:探讨冠心病患者经皮冠状动脉介入术(PCI)术后联合应用尼可地尔与阿托伐他汀的治疗效果。方法:抽取2018年2月至2019年10月山西......
目的 探讨低剂量阿托伐他汀联合依折麦布对老年高脂血症患者的临床效果?方法 本研究以我院于2018年12月至2020年12月收治的200例老......
目的 探究老年缺血性脑卒中患者采用阿托伐他汀治疗对其氧化应激与脂质过氧化水平的影响?方法于2017年4月至2019年7月， 随机选取本......
Atorvastatin upregulates osteoblastic bone markers expression and promote implant osseointegration i
Objective:Atorvastatin was recently reported to reduce bone loss and fracture. But its effect on implant fixation is sti......
目的 Statins are the most effective drugs in the reduction of intracellular synthesis of cholesterol.Many studies proved......
Protective effect of Atorvastatin on cerebral vessels autoregulation in an experimental rabbit model
Objective: To assess the therapeutic effect of Atorvastatin on cerebral vessel autoregulation and explore the underlying......
Therapeutic effects of exosomes derived from atorvastatin-modified bone marrow dendritic cells on ex
Background: We have demonstrated previously that spleen-derived dendritic cells (DCs) modified with atorvastatin can sup......
Atorvastatin has been shown to affect cognitive functions in rodents and humans.However,the underlying mechanism is not ......
Objective: Although it is well known that apoptosis contributes to cancer cell death,the role of autophagy in cancer cel......
Protective effect of atorvastatin on contrast-induced nephropathy in aged diabetics underwent corona
Aim: In this study, the protective effect of different doses of atorvastatin on contrarst-induced nephropathy (CIN) in a......
Atorvastatin increase CRPC radiosensitivity via depressing intracellular ROS metabolism and cell cyc
Poor radiosensitivity is accompanied with castrate resistant prostate cancer (CRPC) progression, a few articles reported......
The independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the
To evaluate the independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and atorvastati......
Evaluation of Combined Anti-atherogenic Effects of Probucol and Cilostazol with Atorvastatin: A Comp
Background and Aim Lipid-lowering therapy is the major choice for the treatment and prevention of cardiovascular disease......
Objective:Lysophosphatidic acid (LPA) is released from activated platelets.Statins are the commonly used anti-atheroscle......
Parathyroid hormone related protein enhanced atherosclerosis in adventitia removal induced rabbit at
Objective To explore the role of parathyroid hormone-related protein(PTHrP) in atheroecelrotic pathological process and ......
Atorvastatin alters the expression of genes related to inflammation, bile acid metabolism and circad
Statins are 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors clinically used for hyperlipidemia.Statins are ge......
...
Short-term intensive atorvastatin therapy improves endothelial function partly via attenuating periv
...
Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmo
...
目的观察阿托伐他汀联合人脐带间充质干细胞移植治疗猪急性心肌梗死的疗效。方法采集人脐带，分离、培养、扩增间充质干细胞至第6代，......
目的探讨阿托伐他汀和普伐他汀治疗高龄冠状动脉粥样硬化性心脏病(CHD)的效果。方法选取2018年9月至2019年2月厦门弘爱医院老年科......
The utility of endogenous glycochenodeoxycholate-3-sulfate and 4β-hydroxycholesterol to evaluate the
The liver is an important organ for drugs disposition,and thus how to accurately evaluate hepatic clearance is essential......
目的分析阿托伐他汀联合氯吡格雷治疗冠心病心绞痛的效果。方法抽取2020年5月至2021年5月濮阳市安阳地区医院收治的冠心病心绞痛患......
目的:针对曲美他嗪联合阿托伐他汀治疗冠心病心绞痛伴血脂异常的治疗效果进行探究.方法:选取本院于2019年1月至2021年5月期间收治......
目的研究通心络胶囊治疗2型糖尿病动脉粥样硬化的临床疗效。方法选取2017年1月至2018年12月间锦州医科大学附属第一医院收治的96例......
目的探讨不同剂量他汀对急性心肌梗死炎症因子超敏C－反应蛋白(hs－CRP)、白细胞介素－6(IL－6)的影响。方法选取2014年1月至2015年6月治疗......
目的探讨长期抗压联合阿托伐他汀治疗对伴高胆固醇血症高血压患者的心肌保护作用。方法将95例伴高胆固醇血症高血压患者随机分为对......
目的分析依折麦布联合阿托伐他汀对低密度脂蛋白-胆固醇(LDL-C)未达标急性冠状动脉综合征患者易损斑块的影响。方法选取2016年1月......
目的探讨小牛血清去蛋白注射液联合阿托伐他汀治疗急性脑梗死的临床效果。方法选择2015年1月至2018年1月山西省侯马市人民医院神经......
目的评价经皮冠状动脉介入术(PCI)术前患者使用不同剂量的阿托伐他汀对围术期临床相关生理指标与心肌损伤的影响。方法选取择期行......
目的分析贝那普利联合阿托伐他汀治疗糖尿病肾病患者的效果。方法回顾性分析山西中医学院中西医结合医院2016年7月至2018年2月收治......
在美国通常使用的3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂如Sim-vastatin(S)、Pravastatin(P)、Lovastatin(L)、和Fluvas......
13名 2型糖尿病人其中男 5,女 5,平均年龄 :6 0 0± 6岁 ,体重指数 30 0± 30ｋｇ/ｍ2 ,病程 12± 7年 ,血红蛋白ＡＩＣ7 3± 1 1% ,ＬＤＣ -Ｃｈ 135ｍｇ/ｄＬ ......
Atorvastatin has been shown to reduce early brain edema and neuronal death after subarachnoid hemorrhage, but its mechan......
目的:本研究旨在观察单次应用大剂量阿托伐他汀80 mg于24 h内能否改善活动平板所诱发的心肌缺血,并探讨可能的机制.方法:本研究采......
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated age
Alzheimer’s disease is a neurodegenerative disorder characterized by progressive cognitive impairment and neuropatholog......
Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inlfammatory and ant
In addition to its lipid-lowering effect, atorvastatin exerts anti-inflammatory and antioxidant effects as well. In this......
目的 观察阿托伐他汀对急性脑梗死患者临床疗效和调脂及C-反应蛋白(CRP)水平的影响.方法 60例急性脑梗死患者给予阿托伐他汀20 mg,......
目的 探讨急性冠脉综合征(ACS)患者外周血单个核细胞环氧化酶2(COX-2)、血小板活化因子乙酰水解酶(PAF-AH)与血清超敏C反应蛋白(hs......
目的 观察阿托伐他汀对血脂正常的初诊2型糖尿病大血管病变患者超敏C反应蛋白(hs-CRP)的影响.方法 96例患者随机分为治疗组49例和......
目的 观察普罗布考联合阿托伐他汀治疗不稳定型心绞痛的临床疗效及安全性.方法 100例不稳定型心绞痛患者按随机原则分为A组和B组各......
目的探讨阿托伐他汀片联合维生素E治疗颈动脉斑块和内膜增厚的临床疗效及其机制。方法100例中老年颈动脉斑块患者随机分成对照组和......
目的 探讨阿托伐他汀治疗腔隙性脑梗死的临床疗效及对脑血管反应性(CVR)的影响.方法 60例腔隙性脑梗死患者按入院单双号随机分为观......
目的 探讨载脂蛋白B(ApoB)基因突变对阿托伐他汀调脂作用的影响.方法 选取152例高脂血症患者为研究对象,采用聚合酶链反应-限制性......
目的 探讨阿托伐他汀对老年卒中患者动脉粥样硬化斑块及预后的影响.方法 124例脑卒中患者随机分为两组,观察组64例在常规治疗基础......
目的 观察阿托伐他汀联合胺碘酮治疗阵发性心房颤动(简称房颤)的有效性和安全性.方法 120例阵发性房颤患者按数字表法随机分为两组......
